Literature DB >> 26119938

Deacetylation of HSPA5 by HDAC6 leads to GP78-mediated HSPA5 ubiquitination at K447 and suppresses metastasis of breast cancer.

Y-W Chang1, C-F Tseng1,2, M-Y Wang3, W-C Chang4, C-C Lee5, L-T Chen1, M-C Hung6, J-L Su1,4,7,8.   

Abstract

Heat-shock protein 5 (HSPA5) is a marker for poor prognosis in breast cancer patients and has an important role in cancer progression, including promoting drug resistance and metastasis. In this study, we identify that the specific lysine residue 447 (K447) of HSPA5 could be modified with polyubiquitin for subsequent degradation through the ubiquitin proteasomal system, leading to the suppression of cell migration and invasion of breast cancer. We further found that GP78, an E3 ubiquitin ligase, interacted with the C-terminal region of HSPA5 and mediated HSPA5 ubiquitination and degradation. Knock down of GP78 significantly increased the expression of HSPA5 and enhanced migration/invasive ability of breast cancer cells. Knock down of histone deacetylase-6 (HDAC6) increased the acetylation of HSPA5 at lysine residues 353 (K353) and reduced GP78-mediated ubiquitination of HSPA5 at K447 and then increased cell migration/invasion. In addition, we demonstrate that E3 ubiquitin ligase GP78 preferentially binds to deacetylated HSPA5. Notably, the expression levels of GP78 inversely correlated with HSPA5 levels in breast cancer patients. Patients with low GP78 expression significantly correlated with invasiveness of breast cancer, advanced tumor stages and poor clinical outcome. Taken together, our results provide new mechanistic insights into the understanding that deacetylation of HSPA5 by HDAC6 facilitates GP78-mediated HSPA5 ubiquitination and suggest that post-translational regulation of HSPA5 protein is critical for HSPA5-mediated metastatic properties of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26119938     DOI: 10.1038/onc.2015.214

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  70 in total

1.  Guidelines for the design and statistical analysis of experiments using laboratory animals.

Authors:  Michael F W Festing; Douglas G Altman
Journal:  ILAR J       Date:  2002

Review 2.  ER stress and cancer.

Authors:  Amy S Lee; Linda M Hendershot
Journal:  Cancer Biol Ther       Date:  2006-07-01       Impact factor: 4.742

Review 3.  Protein degradation by the ubiquitin-proteasome pathway in normal and disease states.

Authors:  Stewart H Lecker; Alfred L Goldberg; William E Mitch
Journal:  J Am Soc Nephrol       Date:  2006-05-31       Impact factor: 10.121

4.  Overexpression of endoplasmic reticulum molecular chaperone GRP94 and GRP78 in human lung cancer tissues and its significance.

Authors:  Qi Wang; Zhongzhou He; Jinhui Zhang; Yingyan Wang; Tao Wang; Shuping Tong; Liju Wang; Shujing Wang; Yuhua Chen
Journal:  Cancer Detect Prev       Date:  2005-11-16

5.  The tumor autocrine motility factor receptor, gp78, is a ubiquitin protein ligase implicated in degradation from the endoplasmic reticulum.

Authors:  S Fang; M Ferrone; C Yang; J P Jensen; S Tiwari; A M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

6.  Human liver cytochrome P450 3A4 ubiquitination: molecular recognition by UBC7-gp78 autocrine motility factor receptor and UbcH5a-CHIP-Hsc70-Hsp40 E2-E3 ubiquitin ligase complexes.

Authors:  YongQiang Wang; Sung-Mi Kim; Michael J Trnka; Yi Liu; A L Burlingame; Maria Almira Correia
Journal:  J Biol Chem       Date:  2014-12-01       Impact factor: 5.157

7.  Overexpression of the glucose-regulated stress gene GRP78 in malignant but not benign human breast lesions.

Authors:  P M Fernandez; S O Tabbara; L K Jacobs; F C Manning; T N Tsangaris; A M Schwartz; K A Kennedy; S R Patierno
Journal:  Breast Cancer Res Treat       Date:  2000-01       Impact factor: 4.872

8.  CYP3A isoforms in Ewing's sarcoma tumours: an immunohistochemical study with clinical correlation.

Authors:  Hamid Zia; Graeme I Murray; Carrie A Vyhlidal; J Steven Leeder; Ahmed E Anwar; Marilyn M Bui; Atif A Ahmed
Journal:  Int J Exp Pathol       Date:  2015-02-09       Impact factor: 1.925

9.  Identity of the immunoglobulin heavy-chain-binding protein with the 78,000-dalton glucose-regulated protein and the role of posttranslational modifications in its binding function.

Authors:  L M Hendershot; J Ting; A S Lee
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

Review 10.  Cytochrome P450 enzymes: novel options for cancer therapeutics.

Authors:  Morag C E McFadyen; William T Melvin; Graeme I Murray
Journal:  Mol Cancer Ther       Date:  2004-03       Impact factor: 6.261

View more
  30 in total

Review 1.  Unconventional Approaches to Modulating the Immunogenicity of Tumor Cells.

Authors:  Laurence Booth; Jane L Roberts; John Kirkwood; Andrew Poklepovic; Paul Dent
Journal:  Adv Cancer Res       Date:  2018-01-03       Impact factor: 6.242

2.  Salvianolic acid A inhibits tumor-associated angiogenesis by blocking GRP78 secretion.

Authors:  Yufei Yang; Lichao Zhang; Xiaoqin La; Zhuoyu Li; Hanqing Li; Songjia Guo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-12-17       Impact factor: 3.000

Review 3.  Unraveling the regulatory role of endoplasmic-reticulum-associated degradation in tumor immunity.

Authors:  Xiaodan Qin; William D Denton; Leah N Huiting; Kaylee S Smith; Hui Feng
Journal:  Crit Rev Biochem Mol Biol       Date:  2020-07-07       Impact factor: 8.250

4.  Role of HSPA1L as a cellular prion protein stabilizer in tumor progression via HIF-1α/GP78 axis.

Authors:  J H Lee; Y-S Han; Y M Yoon; C W Yun; S P Yun; S M Kim; H Y Kwon; D Jeong; M J Baek; H J Lee; S-J Lee; H J Han; S H Lee
Journal:  Oncogene       Date:  2017-07-31       Impact factor: 9.867

5.  DriverML: a machine learning algorithm for identifying driver genes in cancer sequencing studies.

Authors:  Yi Han; Juze Yang; Xinyi Qian; Wei-Chung Cheng; Shu-Hsuan Liu; Xing Hua; Liyuan Zhou; Yaning Yang; Qingbiao Wu; Pengyuan Liu; Yan Lu
Journal:  Nucleic Acids Res       Date:  2019-05-07       Impact factor: 16.971

6.  Critical review of non-histone human substrates of metal-dependent lysine deacetylases.

Authors:  Tasha B Toro; Terry J Watt
Journal:  FASEB J       Date:  2020-08-30       Impact factor: 5.191

7.  Expression of glucose-regulated protein 78 as prognostic biomarkers for triple-negative breast cancer.

Authors:  Chenlian Yang; Zhiwei Zhang; Yutian Zou; Guanfeng Gao; Lingrui Liu; Haifan Xu; Feng Liu
Journal:  Histol Histopathol       Date:  2019-11-19       Impact factor: 2.303

8.  HSPA5 negatively regulates lysosomal activity through ubiquitination of MUL1 in head and neck cancer.

Authors:  Sun-Yong Kim; Hyo Jeong Kim; Haeng-Jun Kim; Dae Ho Kim; Jae Ho Han; Hyung Kwon Byeon; Keunho Lee; Chul-Ho Kim
Journal:  Autophagy       Date:  2018-02-21       Impact factor: 16.016

9.  Proteomic Characterization of Cytoplasmic Lipid Droplets in Human Metastatic Breast Cancer Cells.

Authors:  Alyssa S Zembroski; Chaylen Andolino; Kimberly K Buhman; Dorothy Teegarden
Journal:  Front Oncol       Date:  2021-06-01       Impact factor: 6.244

10.  HNRNPH1-stabilized LINC00662 promotes ovarian cancer progression by activating the GRP78/p38 pathway.

Authors:  Yong Wu; Qinhao Guo; Xingzhu Ju; Zhixiang Hu; Lingfang Xia; Yu Deng; Ping Zhao; Meng Zhang; Yang Shao; Shenglin Huang; Xianghuo He; Hao Wen; Xiaohua Wu
Journal:  Oncogene       Date:  2021-06-19       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.